{{Rsnum
|rsid=3802458
|Gene=C9orf3
|Chromosome=9
|position=94978992
|Orientation=minus
|GMAF=0.08173
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=C9orf3
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 0.0 | 2.7 | 97.3
| HCB | 4.4 | 16.9 | 78.7
| JPT | 0.0 | 12.4 | 87.6
| YRI | 3.4 | 38.1 | 58.5
| ASW | 1.8 | 29.8 | 68.4
| CHB | 4.4 | 16.9 | 78.7
| CHD | 0.9 | 24.8 | 74.3
| GIH | 0.0 | 15.8 | 84.2
| LWK | 3.7 | 44.0 | 52.3
| MEX | 0.0 | 1.7 | 98.3
| MKK | 1.3 | 30.1 | 68.6
| TSI | 0.0 | 2.0 | 98.0
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=20932654
|Trait=None
|Title=Genome-Wide Association Study to Identify Single Nucleotide Polymorphisms (SNPs) Associated With the Development of Erectile Dysfunction in African-American Men After Radiotherapy for Prostate Cancer
|RiskAllele=
|Pval=0.000004
|OR=10.53
|ORtxt=[NR]
|OA=1
}}

{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}